Suchergebnisse - "Pérez-de-Llano, Luis"

PubPharm (147)

31

Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma : The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score

enthalten in: The journal of allergy and clinical immunology. In practice | 2021

von Pérez de Llano, L. | Dávila, I. | Martínez-Moragón, E. | +43

32

Treatment of Moderate-severe Asthma : An Alternative Strategy to the Guidelines Recommendations

enthalten in: Archivos de bronconeumologia | 2021

von Pérez de Llano, L. | Quirce Gancedo, S. | Plaza Moral, V.

33

Effectiveness of Text Message Reminders on Adherence to Inhaled Therapy in Patients With Asthma : Prospective Multicenter Randomized Clinical Trial

enthalten in: JMIR formative research | 2021

von Almonacid, C. | Melero, C. | López Viña, A. | +9

34

Distilling Fact from the Vapor of Nuance : Asthma Exacerbations

enthalten in: The journal of allergy and clinical immunology. In practice | 2021

von Pérez de Llano, L. | Dacal-Rivas, D. | Blanco-Cid, N. | +1

CommentOn: J Allergy Clin Immunol Pract. 2021 Feb;9(2):830-841.e14. - PMID 33011298

35

EAACI Biologicals Guidelines-Recommendations for severe asthma

enthalten in: Allergy | 2021

von Agache, I. | Akdis, C. | Akdis, M. | +28

36

Phenotype-Guided Asthma Therapy : An Alternative Approach to Guidelines

enthalten in: Journal of asthma and allergy | 2021

von Pérez de Llano, L. | Dacal Rivas, D. | Blanco Cid, N. | +1

37

COVID-19 pneumonia in Galicia (Spain) : Impact of prognostic factors and therapies on mortality and need for mechanical ventilation

enthalten in: PloS one | 2021

von Pérez-de-Llano, L. | Romay-Lema, E. | Baloira-Villar, A. | +15

38

EAACI Biologicals Guidelines—Recommendations for severe asthma

enthalten in: Allergy | 2021

von Agache, I. | Akdis, C. | Akdis, M. | +28

39

Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors

enthalten in: Medicina clinica | 2020

von Golpe, R. | Pérez-de-Llano, L. | Dacal, D. | +4

40

Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors

enthalten in: Medicina clinica (English ed.) | 2020

von Golpe, R. | Pérez-de-Llano, L. | Dacal, D. | +4